1 These parameters
incompletely account for substantial interindividual sus
2 us amount of MS data generated often remains
incompletely analyzed due to a lack of sophisticated bio
3 gressive fatal cardiac and skeletal myopathy
incompletely attenuated by synthetic GAA intravenous inf
4 adigms for primary cardiovascular prevention
incompletely capture a polygenic susceptibility to CAD.
5 is harbours secondary green plastids, but an
incompletely characterised proteome precludes accurate u
6 sorders, but their molecular aetiologies are
incompletely characterised.
7 d comprise the microvessel structure, remain
incompletely characterized, particularly in humans.
8 Factors mediating the residual risk are
incompletely characterized.
9 ancer (CRC), but the underlying mechanism is
incompletely characterized.
10 main unknown, and the long-term outcomes are
incompletely characterized.
11 lopment, but their lineage potential remains
incompletely characterized.
12 en receiving antiretroviral therapy (ART) is
incompletely characterized.
13 ediators of islet cellular cross talk remain
incompletely characterized.
14 cts of proton pump inhibitor (PPI) drugs are
incompletely characterized.
15 relative rarity, the natural history remains
incompletely characterized.
16 tic autoimmunity to inflammatory disease are
incompletely characterized.
17 ARC and the role this plays in hemolysis are
incompletely characterized.
18 ns poorly understood and their phenomenology
incompletely characterized.
19 aches, but their antiviral mechanisms remain
incompletely characterized.
20 eneity and differentiation landscape remains
incompletely characterized.
21 s expression during ageing and in AD remains
incompletely clear.
22 d indicates persistent inflammation which is
incompletely controlled.
23 ge III/IV at diagnosis (48%), are frequently
incompletely debulked (44%) and demonstrate inferior sur
24 ion of an arrhythmic MVP (AMVP) form remains
incompletely defined and uncertain.
25 Through
incompletely defined mechanisms, CovR/S and RocA repress
26 or (EF), respectively, play an important yet
incompletely defined role in the pulmonary pathophysiolo
27 V infection and the changes over time remain
incompletely defined, we examined CMV diversity and chan
28 to induce acute synaptic dysfunction remain
incompletely defined, we recently reported that acutely
29 ribed, although indications and outcomes are
incompletely defined.
30 ty; however, its genetic determinants remain
incompletely defined.
31 ne homeostasis, though the exact origins are
incompletely defined.
32 its activity as an extracellular molecule is
incompletely defined.
33 that contribute to the fibrotic response are
incompletely defined.
34 f these molecules on immune responses remain
incompletely defined.
35 ctors that control Th17 pathogenicity remain
incompletely defined.
36 s, which, in almost all populations, remains
incompletely defined.
37 he mechanisms and tissue sites of action are
incompletely defined.
38 transplant recipients in the current era are
incompletely defined.
39 specificities of most RBPs remain unknown or
incompletely defined.
40 nduced by fungal cell walls in CGD are still
incompletely defined.
41 tacatenin nucleocytoplasmic shuttling remain
incompletely defined.
42 antigen specificities of CD8-MP cells remain
incompletely defined.
43 important in regulating WNV replication are
incompletely defined.
44 on between area surgery rates and CSS remain
incompletely defined.
45 ance contributes to its pathogenesis through
incompletely-
defined mechanisms.
46 The pathophysiology is
incompletely delineated.
47 tients free of significant complications are
incompletely described.
48 loci vary in effect across space and time is
incompletely described.
49 rs and resistors of the PD-1 response remain
incompletely elucidated.
50 eptibility to atrial alternans in HF remains
incompletely elucidated.
51 Histopathological images are a rich but
incompletely explored data type for studying cancer.
52 rocytes contribute to brain disorders remain
incompletely explored.
53 witterionic and cationic PFASs, which may be
incompletely extracted from subsurface solids by analyti
54 plication in which structural instability of
incompletely glycosylated PrP contributes to the conform
55 t, but the necessary brain components remain
incompletely identified.
56 helial neoplasias in KPC/Cdh11(+/+) mice and
incompletely in KPC/Cdh11(+/-) and KPC/Cdh11(-/-) mice,
57 in an mRNA transcript because 1,N (6)-erA is
incompletely incised by RNase H2.
58 itions, consistent with joint molecules with
incompletely invaded 3' ends.
59 the association to mortality largely remain
incompletely investigated.
60 h wood-decay and fruiting body formation are
incompletely known.
61 sk factors develop across the life course is
incompletely known.
62 ons were categorized as completely (100%) or
incompletely (&
lt;=99%) necrotic based on transplant histol
63 ivocal by consensus, with most (five of six)
incompletely necrotic at histopathology.
64 s rated as treatment response equivocal were
incompletely necrotic at histopathology.
65 Most real-world networks are
incompletely observed.
66 zygotes showed a palate elevation delay with
incompletely penetrant cleft palate.
67 transcript missing exon 3, suggestive of an
incompletely penetrant splice defect.
68 al, double heterozygous embryos exhibited an
incompletely penetrant syndrome of CHDs with heterotaxy.
69 ification among individuals with highly, but
incompletely,
penetrant genetic variants.
70 ings highlight that aPL testing may often be
incompletely performed.
71 metabolic interactions that were falsely or
incompletely predicted by existing methods, including pr
72 neuroinflammation were significantly, though
incompletely,
prevented.
73 est a critical function of FANCJ to suppress
incompletely processed and toxic joint DNA molecules dur
74 E. coli tol-pal mutants are connected by an
incompletely processed peptidoglycan (PG) layer.
75 efits they provide are poorly understood and
incompletely quantified.
76 the next event.Objectives: To assess whether
incompletely recovered COPD exacerbations benefit from a
77 Missing data were often
incompletely reported, and continuous predictors were co
78 il to capture such transitions and therefore
incompletely represent care outcomes over time.
79 higher frequency of DNA breaks in PSCs with
incompletely reprogrammed DNA replication were found.
80 fferentiation potential, DNA replication was
incompletely reprogrammed, and genomic instability incre
81 colorectal polyps 1 to 20 mm are frequently
incompletely resected, and that risk increases for polyp
82 organized thrombotic material stemming from
incompletely resolved acute pulmonary embolism.
83 ether further therapy with ciprofloxacin for
incompletely resolved COPD exacerbations prolonged the t
84 re formed and regulated within cells remains
incompletely resolved.
85 ation of hypothalamic hunger neurons that is
incompletely reversed by weight loss and may contribute
86 is exported from the nucleus in unspliced or
incompletely spliced forms to serve as templates for tra
87 a flexneri or Salmonella Typhimurium remains
incompletely understood [5, 6].
88 thelial regeneration and vascular repair are
incompletely understood and constitute an emerging area
89 However, the pathophysiology is
incompletely understood and specific therapy is lacking.
90 The reasons are
incompletely understood as potential underlying pathomec
91 that govern fetomaternal tolerance are still
incompletely understood but may provide critical insight
92 ain unclear due to complex, fluctuating, and
incompletely understood developmental conditions.
93 the factors that govern host tropism remains
incompletely understood for most pathogens.
94 It is
incompletely understood how cancer cells escape NK cell
95 It remains
incompletely understood how TNF can lead to different di
96 ved around the time of fertilization through
incompletely understood mechanisms.
97 risk factor for many human disorders through
incompletely understood mechanisms.
98 ients in the recent DAPAHF clinical trial by
incompletely understood mechanisms.
99 iomyopathies, which promote heart failure by
incompletely understood mechanisms.
100 olution of experimental lung inflammation by
incompletely understood mechanisms.
101 scular endothelial cell (EC) interactions by
incompletely understood mechanisms.
102 ugh different pathways and have distinct but
incompletely understood morphogenetic functions during c
103 is a devastating gastrointestinal disease of
incompletely understood pathophysiology predominantly af
104 nt.IMPORTANCE Nonenveloped virus entry is an
incompletely understood process.
105 nderstanding better both nucleases and their
incompletely understood roles in vitro and in vivo.
106 tional yet structurally and biosynthetically
incompletely understood varieties of melanin: eumelanin,
107 pneumoniae to cause infection, but it is an
incompletely understood virulence trait.
108 le of these pathways in different tissues is
incompletely understood, an issue particularly relevant
109 erentiation of specific nephron segments are
incompletely understood, and the factors that maintain t
110 regulation of mucociliary transport remains
incompletely understood, and therapeutic targets for its
111 se mechanisms underlying these processes are
incompletely understood, and were proposed to differ bet
112 etabolism, cofactor binding interactions are
incompletely understood, as is the molecular basis for p
113 The pathophysiology remains
incompletely understood, but it is probably related to d
114 thophysiology of irritable bowel syndrome is
incompletely understood, but it is well established that
115 coronavirus disease 2019 (COVID-19) is still
incompletely understood, but it seems to involve immune
116 ms linking age and body weight to cancer are
incompletely understood, but recent studies have provide
117 Key aspects of its pathogenesis are still
incompletely understood, but severe brain swelling ident
118 polyP, a molecule with prominent, yet often
incompletely understood, contributions to cellular funct
119 m cells to neuronal and glial generation are
incompletely understood, despite their importance for ne
120 n to downstream physiological systems remain
incompletely understood, however.
121 The mechanisms of proton delivery are
incompletely understood, in part due to an absence of in
122 ersons with infectious tuberculosis (TB) are
incompletely understood, particularly the number of expo
123 and signal coupling of these proteins remain
incompletely understood, particularly upon expression of
124 rise to these pronounced differences remain
incompletely understood, they are generally attributed t
125 Since underlying mechanics are
incompletely understood, we investigated left ventricula
126 roperties of pristine graphene flakes remain
incompletely understood, with conflicting reports about
127 pathways promoting excessive activation are
incompletely understood, with limited experimental model
128 f anesthetic-induced unconsciousness remains
incompletely understood, with some advocating for a quan
129 s adipocyte development and function remains
incompletely understood.
130 for regular bone formation, however, remain
incompletely understood.
131 allosteric mechanism by which this occurs is
incompletely understood.
132 y profile of common anti-VEGF agents remains
incompletely understood.
133 ffected with diffuse white matter injury, is
incompletely understood.
134 transfer and B cell activation by DCs remain
incompletely understood.
135 ligands, but how neurexins are regulated is
incompletely understood.
136 chanisms controlling recognition of GSLs are
incompletely understood.
137 specificity of these signaling pathways are
incompletely understood.
138 re initiated following virus recognition are
incompletely understood.
139 influences on intestinal development remain
incompletely understood.
140 isms underpinning cancer cell plasticity are
incompletely understood.
141 ng multiple NAD(+) biosynthesis pathways are
incompletely understood.
142 HIFalpha in developmental myelination remain
incompletely understood.
143 syndrome, but the underlying mechanisms are
incompletely understood.
144 cal trials, but its clinical significance is
incompletely understood.
145 th taking at any particular point in time is
incompletely understood.
146 ring events for acute aortic dissections are
incompletely understood.
147 g ZIKV infection and pathogenic outcomes are
incompletely understood.
148 ts of ER stress on beta-cell function remain
incompletely understood.
149 subsets and associated protein expression is
incompletely understood.
150 f effector T cell-derived chemokines remains
incompletely understood.
151 hanism of BAX and BAK pore formation remains
incompletely understood.
152 ions has only recently been addressed and is
incompletely understood.
153 ficity of the gammadelta T cell receptors is
incompletely understood.
154 chanisms by which mosaic vessels form remain
incompletely understood.
155 r mechanisms that govern these processes are
incompletely understood.
156 L-1beta-mediated viral RNA reduction remains
incompletely understood.
157 ic changes that underlie this malignancy are
incompletely understood.
158 ecular basis for mastermind function remains
incompletely understood.
159 chanisms underlying this coordination remain
incompletely understood.
160 ng factors orchestrating these events remain
incompletely understood.
161 A receptors and the induction mechanisms are
incompletely understood.
162 ical and pathophysiological responses remain
incompletely understood.
163 avior through molecular programs that remain
incompletely understood.
164 on and importance in brain physiology remain
incompletely understood.
165 re and neural dysfunctions over time remains
incompletely understood.
166 olecular targets, and thereby the genes, are
incompletely understood.
167 confined migration-induced DNA damage remain
incompletely understood.
168 ich epithelial cells sense tissue damage are
incompletely understood.
169 euronal circuits mediating these effects are
incompletely understood.
170 ollaborates with c-Myc in lymphomagenesis is
incompletely understood.
171 but the consequences of 12HBA abundance are
incompletely understood.
172 nd function of lung EC heterogeneity remains
incompletely understood.
173 xactly how beta-catenin inhibits WT1 remains
incompletely understood.
174 lar mechanisms underlying this crosstalk are
incompletely understood.
175 ng inflammation; however, the mechanisms are
incompletely understood.
176 the mechanisms that control persistence are
incompletely understood.
177 s underlying allosteric PfPKG inhibition are
incompletely understood.
178 Mechanisms and risk factors are
incompletely understood.
179 ns traffic to this proximal axonal domain is
incompletely understood.
180 impact of these radicals on gut microbes is
incompletely understood.
181 causes of multiple congenital anomalies are
incompletely understood.
182 cast information to cortical networks remain
incompletely understood.
183 2 in directing de novo TE methylation remain
incompletely understood.
184 erlying this activation process of plexin is
incompletely understood.
185 t underlie heightened pain processing remain
incompletely understood.
186 Clostridioides difficile infection (CDI) is
incompletely understood.
187 involvement in lung cancer, if any, remains
incompletely understood.
188 variety of diseases, but how this occurs is
incompletely understood.
189 xes (ICs), but the underlying mechanisms are
incompletely understood.
190 ination, though underlying mechanisms remain
incompletely understood.
191 troke and dementia, but its genetic basis is
incompletely understood.
192 ypertrophic growth and heart failure remains
incompletely understood.
193 sus (SLE), but the underlying mechanisms are
incompletely understood.
194 and disease severity and adverse outcomes is
incompletely understood.
195 y for proper lamination in these tissues are
incompletely understood.
196 , the regulatory pathway and outcomes remain
incompletely understood.
197 orage and subsequent BDNF quantification are
incompletely understood.
198 ted in the differentiation of LPCs are still
incompletely understood.
199 programming, but the underlying mechanism is
incompletely understood.
200 eservoir for lifelong EBV infection, remains
incompletely understood.
201 ts a breach of its epithelial border remains
incompletely understood.
202 utoreactive antibody responses in humans are
incompletely understood.
203 nutrient transport across their membranes is
incompletely understood.
204 ed fusogenicity of different MuV strains are
incompletely understood.
205 NPCs, but the chromatin-based mechanisms are
incompletely understood.
206 cytokine production, but these pathways are
incompletely understood.
207 al mechanisms leading to hypertension remain
incompletely understood.
208 specially the transcallosal pathway, remains
incompletely understood.
209 sms that underlie this susceptibility remain
incompletely understood.
210 port, and transport to integration sites are
incompletely understood.
211 ring systemic metabolic perturbations remain
incompletely understood.
212 gnition and uptake, several key areas remain
incompletely understood.
213 owever, the underlying mechanism(s) remained
incompletely understood.
214 mammalian cells form such a nucleus remains
incompletely understood.
215 nsplantation, the mechanisms involved remain
incompletely understood.
216 ity, limits therapeutic success, and remains
incompletely understood.
217 DK4/6 is activated relative to CDK2 remained
incompletely understood.
218 programs mediating tumor suppression remain
incompletely understood.
219 ver, underlying dentoalveolar defects remain
incompletely understood.
220 ism underlying the oncogenic role of WASp is
incompletely understood.
221 ver, the proteomics of hematopoiesis remains
incompletely understood.
222 genitors into these cell types, however, are
incompletely understood.
223 fibroblasts but underlying mechanisms remain
incompletely understood.
224 in neurons, the role of PS1 in microglia is
incompletely understood.
225 f aging-related disease, such as cancer, are
incompletely understood.
226 tively called beige or brite adipocytes, are
incompletely understood.
227 eria acquire iron during gut inflammation is
incompletely understood.
228 that allow W to modulate innate immunity are
incompletely understood.
229 ystem and their underlying mechanisms remain
incompletely understood.
230 activity in HF, but these pathways are still
incompletely understood.
231 nical study, the mechanism of action remains
incompletely understood.
232 mechanisms that determine these outcomes are
incompletely understood.
233 sp104 hexamers disaggregate proteins remains
incompletely understood.
234 an withstand endogenous hydrogen peroxide is
incompletely understood.
235 on within the tumor microenvironment remains
incompletely understood.
236 ly recognized and removed from organelles is
incompletely understood.
237 However, the molecular mechanisms are still
incompletely understood.
238 the immune response to prostate infection is
incompletely understood.
239 infection leads to subsequent disease remain
incompletely understood.
240 titerritorial subclinical atherosclerosis is
incompletely understood.
241 nd conduction of APs at mammalian NRs remain
incompletely understood.
242 ell differentiation, though the mechanism is
incompletely understood.
243 The cues that promote this confinement are
incompletely understood.
244 lar and molecular mechanisms responsible are
incompletely understood.
245 intertwined DNA repair and transcription is
incompletely understood.
246 ver, the pathogenesis of myocarditis remains
incompletely understood.
247 gy that predispose to metabolic syndrome are
incompletely understood.
248 idities, and mortality from COVID-19 remains
incompletely understood.
249 orticoid action and whole-body metabolism is
incompletely understood.
250 of astrocytes within neural circuits remain
incompletely understood.
251 eptor signaling that promote axon growth are
incompletely understood.
252 ng, with the underlying molecular mechanisms
incompletely understood.
253 storage, consolidation and retrieval remain
incompletely understood.
254 high mortality, yet the pathogenesis remains
incompletely understood.
255 LE) on subcortical arousal structures remain
incompletely understood.
256 ng although the underlying mechanism remains
incompletely understood.
257 pects of cancer, its role in this disease is
incompletely understood.
258 a-dependent cyst progression in ADPKD remain
incompletely understood.
259 ability and energy landscape of proteins are
incompletely understood.
260 ations lead to the migraine phenotype remain
incompletely understood.
261 sual cues on the processing of speech remain
incompletely understood.
262 e molecules mediating their crosstalk remain
incompletely understood.
263 he signaling mediates AD pathologies remains
incompletely understood.
264 the mechanism underlying this phenomenon is
incompletely understood.
265 chromatin opening by mechanisms that remain
incompletely understood.
266 ysiological role and molecular regulation is
incompletely understood.
267 +) (mtCa(2+)) regulates tumorigenesis remain
incompletely understood.
268 but the underlying circuit mechanism remains
incompletely understood.
269 t their specialised functions in mitosis are
incompletely understood.
270 2 engages with native-like chromatin remains
incompletely understood.
271 n metastasis but its molecular basis remains
incompletely understood.
272 nt to inflammatory micro-environments remain
incompletely understood.
273 S-mediated macroautophagy stimulation remain
incompletely understood.
274 role of RSV genotypes in human infection is
incompletely understood.
275 ociated factors that drive functionality are
incompletely understood.
276 clinical problem of which the mechanisms are
incompletely understood.
277 tion both centrally and peripherally remains
incompletely understood.
278 the mechanisms that govern this process are
incompletely understood.
279 nisms responsible for these phenomena remain
incompletely understood.
280 ) and amyotrophic lateral sclerosis (ALS) is
incompletely understood.
281 hat enforce dependence on co-stimulation are
incompletely understood.
282 The role of TCR in tTreg selection remains
incompletely understood.
283 velopment, but the underlying mechanisms are
incompletely understood.
284 ors, but the nature of these associations is
incompletely understood.
285 tion, and repair of germ cell genomes remain
incompletely understood.
286 nisms governing their quality control remain
incompletely understood.
287 function of the isoforms, MR1B and MR1C, are
incompletely understood.
288 owever, the mechanism of its biosynthesis is
incompletely understood.
289 in disease, its pathogenic mechanisms remain
incompletely understood.
290 ation of gammadelta T cells in the thymus is
incompletely understood.
291 ial signaling dynamics in CD8 T cells remain
incompletely understood.
292 substrates for top-down sensory control are
incompletely understood.
293 chanisms behind this cellular process remain
incompletely understood.
294 that govern its spatial organization remain
incompletely understood.
295 ogenesis, but the relevant mechanisms remain
incompletely understood.
296 s linking obesity with these diseases remain
incompletely understood.
297 Its inflammatory characteristics are
incompletely understood.Objectives: To define the cytoki
298 lying the development of immunopathology are
incompletely understood.Objectives: We aimed to identify
299 ure death and incident complications remains
incompletely understood; likewise, the potential reasons
300 of common additives/impurities or unreacted/
incompletely utilized reagents or catalysts.